Replies to post #1352 on Tetraphase Pharmaceuticals, Inc. (TTPH)

[rusty8350]

Still sounds like FDA news is imminent. The CEO knocked it out of the park in my opinion today with describing why this antibiotic is so important and why it can be so valuable as well, given no other treatment options are available that compare. He even discussed adding additional indications in the future as well, other than the cIAI and cUTI they're currently pursuing.

Went more in depth on the data they have showing how well the IV use of the drug did in the cUTI trial and where it worked in patients with resistance to the competition.

We're just waiting for the fda still. But they're expecting that news literally any day now and are continuing development of eravacycline in the meantime as well as some of their other pipeline drugs.

Sounds very positive in my opinion.